Vaccines Market by Technology (Conjugate Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Inactivated and Subunit Vaccines and Recombinant Vaccines), Type (Monovalent Vaccines and Multivalent Vaccines), Disease Indication (Pneumococcal Disease, Influenza, Meningococcal Disease, Rotavirus, MMR, Dengue, DTP, HPV, Polio, Hepatitis, Varicella and Herpes Zoster), Route of Administration (Oral Administration, Intramuscular and Subcutaneous Administration) and Patient Type (Pediatric Patients, Adult Patients) – Analysis & Forecast 2019-2030

Report ID : 81  |  Published Date : May 2019  |  Pages : 150  |  Region : global  |  Report Code : PH-3




Vaccines Market Overview and Introduction

Vaccines market was estimated to be over US$ 30.0 Bn in 2018 and is likely to clock a significant CAGR from 2019 to 2030.

Vaccines are biological preparations which are used to boost immunity by activating acquired immunity against a particular disease. Vaccines typically constitutes of agents resembling a disease-causing microorganism. It is fabricated from either a weakened or killed form of the microbe, its surface protein or toxins. The process of administration of vaccine is known as vaccination. The vaccination agent assists the body in recognizing the agent as a threat and destroys it. Moreover, it helps the body to recognize and destroy any microorganism associated with the agent for future encounters.

Rising incidences and prevalence of several diseases, namely hepatitis, tuberculosis, influenza and cholera is anticipated to ensure a strong demand for vaccination products worldwide. Similarly, growing support from both government and non-government establishments have been pivotal in contributing the growth of the global vaccines market. Moreover, growing initiatives to support immunization drives across developing economies, economies in transition and developed economies to control and eradicate vaccine-preventable diseases can primarily be attributed for the extensive adoption of vaccines globally. However, high costs associated with development, storage is likely to restrain the market to a certain extent.

Vaccines Market by Technology

On the basis of technology, the vaccines market can be segmented into conjugate vaccines, live attenuated vaccines, toxoid vaccines, inactivated and subunit vaccines and recombinant vaccines. The conjugate vaccine segment accounted for the largest market share in the global vaccines market, owing to rising company investments and growing government support for development of conjugate vaccines.

Vaccines Market by Type

On the basis of type, the market is segmented into monovalent vaccines and multivalent vaccines. In terms of market share, the segment of monovalent vaccines accounted for the largest share. Growing adoption of monovalent vaccines for combating single diseases, namely dengue, influenza and malaria among others can be attributed to the extensive growth of this segment.

Vaccines Market by Disease Indication

Similarly, in terms of disease indication the vaccines market can be segmented into pneumococcal disease, influenza, meningococcal disease, rotavirus, MMR, dengue, DTP, HPV, Polio, hepatitis, varicella and herpes zoster and other disease indications.

Vaccines Market by Route of Administration

Whereas, the route of administration segment can be classified broadly into three categories, namely oral administration, intramuscular and subcutaneous administration and other routes of administrations. Finally, based on end user the global vaccines market can be segmented into pediatric patients and adult patients.

Vaccines Market by Region

The global vaccines market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market of vaccines market, followed by Europe and Asia Pacific. Asia Pacific is expected to dominate the global vaccines market in the forecast period. Factors such as the increasing investments by market players in emerging economies, rising incidence of diseases, and growing awareness regarding vaccinations to drive market growth in this region 

Vaccines Market Prominent Players

The prominent players in the global vaccines market are Pfizer Inc., GlaxoSmithKline plc., Merck & Co., Inc., Sanofi Pasteur Limited, Emergent BioSolutions Inc., Johnson & Johnson Services, Inc., Serum Institute of India Pvt. Ltd., AstraZeneca, Panacea Biotec Limited, Bavarian Nordic, Biological E and CSL Limited among others

Table of Contents

  1. INTRODUCTION
    1. Market Definition
    2. Market Ecosystem
      1. Market Classification
      2. Geographic Scope
      3. Years Considered for the Study: Historical Years – 2016 & 2017; Base Year – 2018; Forecasted Years – 2019 to 2030
    3. Currency Used
  2. RESEARCH METHODOLOGY
    1. Research Framework
    2. Data Collection Technique
    3. Data Sources
      1. Secondary Sources
      2. Primary Sources
    4. Market Estimation Methodology
      1. Bottoms Up Approach
      2. Top Down Approach
    5. Data Validation and Triangulation
      1. Market Forecasting Model
      2. Limitations/Assumptions of the Study
  3. ABSTRACT OF THE STUDY
  4. MARKET DYNAMICS ASSESMENT
    1. Overview
    2. Drivers
    3. Barriers/Challenges
    4. Opportunities
  5. UNIQUE SELLING PROPOSITIONS (USPs)
    1. Pipeline  Assessment
    2. Epidemiological Assessment: Infectious Diseases
    3. Research Landscape Assessment
  6. GLOBAL VACCINES MARKET- ANALYSIS & FORECAST, BY TECHNOLOGY
    1. Conjugate Vaccines
    2. Live Attenuated Vaccines
    3. Toxoid Vaccines
    4. Inactivated and Subunit Vaccines 
    5. Recombinant Vaccines 
  7. GLOBAL VACCINES MARKET - ANALYSIS & FORECAST, BY TYPE
    1. Monovalent Vaccines 
    2. Multivalent Vaccines
  8. GLOBAL VACCINES MARKET - ANALYSIS & FORECAST, BY DISEASE INDICATION
    1. Pneumococcal Disease 
    2. Influenza 
    3. Meningococcal Disease
    4. Rotavirus 
    5. MMR 
    6. Dengue 
    7. DTP
    8. HPV 
    9. Polio 
    10. Hepatitis 
    11. Varicella 
    12. Herpes Zoster 
    13. Other Disease Indications
  9. GLOBAL MARKET - ANALYSIS & FORECAST, BY ROUTE OF ADMINISTRATION
    1. Oral Administration
    2. Intramuscular and Subcutaneous Administration 
    3. Other Routes of Administrations
  10. GLOBAL MARKET - ANALYSIS & FORECAST, BY PATIENT TYPE
    1. Pediatric Patients 
    2. Adult Patients
  11. GLOBAL MARKET - ANALYSIS & FORECAST, BY REGION
    1. North America Vaccines Market
      1. North America Market, By Country
        1.  US
        2.  Canada
      2. North America Market Analysis & Forecast, By Product
      3. North America Market Analysis & Forecast, By Type
      4. North America Market Analysis & Forecast, By Disease Indication
      5. North America Market Analysis & Forecast, By Route Of Administration
      6. North America Market Analysis & Forecast, By Patient Type
    2. Europe Vaccines Market
      1. Europe Market, By Country/Region
        1. Germany
        2. U.K
        3. France
        4. Rest of Europe (ROE)
      2. Europe Market Analysis & Forecast, By Product
      3. Europe Market Analysis & Forecast, By Type
      4. Europe Market Analysis & Forecast, By Disease Indication
      5. Europe Market Analysis & Forecast, By Route Of Administration
      6. Europe Market Analysis & Forecast, By Patient Type
    3. Asia Pacific Vaccines Market
      1. Asia Pacific Market, By Country/Region
        1. China
        2. Japan
        3. India
        4. Rest of Asia Pacific (RoAPAC)
      2. Asia Pacific Market Analysis & Forecast, By Product
      3.  Asia Pacific Market Analysis & Forecast, By Type
      4. Asia Pacific Market Analysis & Forecast, By Disease Indication
      5. Asia Pacific Market Analysis & Forecast, By Route Of Administration
      6. Asia Pacific Market Analysis & Forecast, By Patient Type
    4. Rest of the World (ROW) Vaccines Market
      1. Rest of the World Market, By Country/ Region
        1. Latin America
        2. Middle East & Africa
      2. Rest of the World Market Analysis & Forecast, By Product
      3. Rest of the World Market Analysis & Forecast, By Type
      4. Rest of the World Market Analysis & Forecast, By Disease Indication
      5. Rest of the World Market Analysis & Forecast, By Route Of Administration
      6. Rest of the World Market Analysis & Forecast, By Patient Type
  12. COMPETETIVE LANDSCAPE
    1. Key Players & Their Competitive Positioning (2018)
    2. Key Strategies Assessment
      1. New Product Launches
      2. Merger & Acquisitions
      3. Agreements, Collaborations, & Partnerships
      4. Expansions
      5. Other Strategies
  13. COMPANY PROFILES (Business Overview, Products Offered, Financial Performance*, Recent Developments)
    1.  Pfizer Inc.
    2. GlaxoSmithKline plc.
    3.  Merck & Co., Inc. 
    4.  Sanofi Pasteur Limited
    5. Emergent BioSolutions Inc.
    6.  Johnson & Johnson Services, Inc.
    7.  Serum Institute of India Pvt. Ltd.
    8.  AstraZeneca  
    9.  Panacea Biotec Limited
    10.  Bavarian Nordic
    11. Biological E
    12. CSL Limited

*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain